Skip to content
2000
Volume 21, Issue 7
  • ISSN: 1573-3947
  • E-ISSN: 1875-6301

Abstract

Lung cancer is the leading cause of cancer-related deaths globally, necessitating ongoing scientific research to understand its detection, treatment, and prevention. Long non-coding RNAs (lncRNAs) are a diverse group of non-coding RNAs that play crucial roles in regulating tumourigenic processes, such as cell proliferation, invasion, and metastasis in non-small cell lung cancer (NSCLC). Despite not encoding proteins, lncRNAs have significant impacts on the development and progression of NSCLC. Recent evidence suggests that lncRNAs may serve as valuable biomarkers for diagnosing and prognosticating NSCLC through tissue or blood analysis, and as potential therapeutic targets. This review provides a comprehensive overview of recent advancements in lncRNA research for NSCLC, offering new insights into their mechanisms of action and potential therapeutic applications. It also explores promising avenues for therapeutic development. By elucidating the complex roles of lncRNAs in NSCLC, this article aims to contribute to the development of innovative diagnostic and therapeutic strategies that can significantly enhance patient outcomes. Understanding the multifaceted functions of lncRNAs in lung cancer has the potential to lead to substantial progress in early disease detection, targeted treatments, and personalised medicine, ultimately improving the prognosis and quality of life for individuals affected by this devastating disease.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cctr/10.2174/0115733947339431241001080157
2024-10-11
2025-12-05

  • From This Site

    /content/journals/cctr/10.2174/0115733947339431241001080157
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. BrayF. LaversanneM. SungH. FerlayJ. SiegelR.L. SoerjomataramI. JemalA. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.202474322926310.3322/caac.2183438572751
     [Google Scholar]
  2. BeermannJ. PiccoliM.T. ViereckJ. ThumT. Non-coding RNAs in development and disease: Background, mechanisms, and therapeutic approaches.Physiol. Rev.20169641297132510.1152/physrev.00041.201527535639
     [Google Scholar]
  3. HongD. XuK. ZhangL. WanX. GuoY. Radiomics signature as a predictive factor for EGFR mutations in advanced lung adenocarcinoma.Front. Oncol.2020102810.3389/fonc.2020.0002832082997
     [Google Scholar]
  4. HuangJ. PanB. XiaG. ZhuJ. LiC. FengJ. LncRNA SNHG15 regulates EGFR-TKI acquired resistance in lung adenocarcinoma through sponging miR-451 to upregulate MDR-1.Cell Death Dis.202011752552510.1038/s41419‑020‑2683‑x32655137
     [Google Scholar]
  5. QuinnJ.J. ChangH.Y. Unique features of long non-coding RNA biogenesis and function.Nat. Rev. Genet.2016171476210.1038/nrg.2015.1026666209
     [Google Scholar]
  6. ZhangY. DongX. GuoX. LiC. FanY. LiuP. YuanD. MaX. WangJ. ZhengJ. LiH. GaoP. LncRNA-BC069792 suppresses tumor progression by targeting KCNQ4 in breast cancer.Mol. Cancer2023221414110.1186/s12943‑023‑01747‑536859185
     [Google Scholar]
  7. MattickJ.S. AmaralP.P. CarninciP. CarpenterS. ChangH.Y. ChenL.L. ChenR. DeanC. DingerM.E. FitzgeraldK.A. GingerasT.R. GuttmanM. HiroseT. HuarteM. JohnsonR. KanduriC. KapranovP. LawrenceJ.B. LeeJ.T. MendellJ.T. MercerT.R. MooreK.J. NakagawaS. RinnJ.L. SpectorD.L. UlitskyI. WanY. WiluszJ.E. WuM. Long non-coding RNAs: Definitions, functions, challenges and recommendations.Nat. Rev. Mol. Cell Biol.202324643044710.1038/s41580‑022‑00566‑836596869
     [Google Scholar]
  8. Gencel-AugustoJ. WuW. BivonaT.G. Long non-coding RNAs as emerging targets in lung cancer.Cancers20231512313510.3390/cancers1512313537370745
     [Google Scholar]
  9. ZhangR. XiaY. WangZ. ZhengJ. ChenY. LiX. WangY. MingH. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer.Biochem. Biophys. Res. Commun.2017490240641410.1016/j.bbrc.2017.06.05528623135
     [Google Scholar]
  10. LiN. WangY. LiuX. LuoP. JingW. ZhuM. TuJ. Identification of circulating long noncoding RNA HOTAIR as a novel biomarker for diagnosis and monitoring of non–small cell lung cancer.Technol. Cancer Res. Treat.20171661060106610.1177/153303461772375428784052
     [Google Scholar]
  11. GuoD. WangY. RenK. HanX. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.Exp. Cell Res.2018362117217910.1016/j.yexcr.2017.11.01429133127
     [Google Scholar]
  12. GaoJ. PanT. WangH. WangS. ChaiJ. JinC. LncRNA FAM138B inhibits the progression of non-small cell lung cancer through miR-105-5p.Cell Cycle202322780881710.1080/15384101.2022.215455636529892
     [Google Scholar]
  13. PontingC.P. OliverP.L. ReikW. Evolution and functions of long noncoding RNAs.Cell2009136462964110.1016/j.cell.2009.02.00619239885
     [Google Scholar]
  14. RansohoffJ.D. WeiY. KhavariP.A. The functions and unique features of long intergenic non-coding RNA.Nat. Rev. Mol. Cell Biol.201819314315710.1038/nrm.2017.10429138516
     [Google Scholar]
  15. YarmishynA.A. KurochkinI.V. Long noncoding RNAs: A potential novel class of cancer biomarkers.Front. Genet.2015614514510.3389/fgene.2015.0014525954300
     [Google Scholar]
  16. PennisiE. Genomics. ENCODE project writes eulogy for junk DNA.Science2012337609911591161, 116110.1126/science.337.6099.115922955811
     [Google Scholar]
  17. XiangJ.F. YinQ.F. ChenT. ZhangY. ZhangX.O. WuZ. ZhangS. WangH.B. GeJ. LuX. YangL. ChenL.L. Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus.Cell Res.201424551353110.1038/cr.2014.3524662484
     [Google Scholar]
  18. MeltonC. ReuterJ.A. SpacekD.V. SnyderM. Recurrent somatic mutations in regulatory regions of human cancer genomes.Nat. Genet.201547771071610.1038/ng.333226053494
     [Google Scholar]
  19. YuanQ. ChuH. GeY. MaG. DuM. WangM. ZhangZ. ZhangW. LncRNA PCAT1 and its genetic variant rs1902432 are associated with prostate cancer risk.J. Cancer2018981414142010.7150/jca.2368529721051
     [Google Scholar]
  20. JiP. DiederichsS. WangW. BöingS. MetzgerR. SchneiderP.M. TidowN. BrandtB. BuergerH. BulkE. ThomasM. BerdelW.E. ServeH. Müller-TidowC. MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer.Oncogene200322398031804110.1038/sj.onc.120692812970751
     [Google Scholar]
  21. FlynnR.A. ChangH.Y. Long noncoding RNAs in cell-fate programming and reprogramming.Cell Stem Cell201414675276110.1016/j.stem.2014.05.01424905165
     [Google Scholar]
  22. YangZ. XuF. TeschendorffA.E. ZhaoY. YaoL. LiJ. HeY. Insights into the role of long non-coding RNAs in DNA methylation mediated transcriptional regulation.Front. Mol. Biosci.20229106740610.3389/fmolb.2022.106740636533073
     [Google Scholar]
  23. ZhuC. WangX. WangY. WangK. Functions and underlying mechanisms of lncRNA HOTAIR in cancer chemotherapy resistance.Cell Death Discov.20228138310.1038/s41420‑022‑01174‑336100611
     [Google Scholar]
  24. BhanA. MandalS.S. LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer. Biochimica et Biophysica Acta (BBA)-.Revis. Cancer201518561151164
     [Google Scholar]
  25. MajelloB. GoriniF. SaccàC.D. AmenteS. Expanding the role of the histone lysine-specific demethylase LSD1 in cancer.Cancers201911332410.3390/cancers1103032430866496
     [Google Scholar]
  26. JangW. ImM. RohJ. KangJ.H. KimW. Hippo-YAP/TAZ pathway regulation: The crucial roles of lncRNAs in cancer.Anim. Cells Syst.202327130932010.1080/19768354.2023.2281370
     [Google Scholar]
  27. Peña-FloresJ.A. Enríquez-EspinozaD. Muela-CamposD. Álvarez-RamírezA. SáenzA. Barraza-GómezA.A. BravoK. Estrada-MacíasM.E. González-AlvaradoK. Functional relevance of the long intergenic non-coding RNA regulator of reprogramming (Linc-ROR) in cancer proliferation, metastasis, and drug resistance.Noncoding RNA2023911210.3390/ncrna901001236827545
     [Google Scholar]
  28. SongH. ChenL. LiuW. XuX. ZhouY. ZhuJ. ChenX. LiZ. ZhouH. Depleting long noncoding RNA HOTAIR attenuates chronic myelocytic leukemia progression by binding to DNA methyltransferase 1 and inhibiting PTEN gene promoter methylation.Cell Death Dis.202112544010.1038/s41419‑021‑03637‑433941772
     [Google Scholar]
  29. GibneyE.R. NolanC.M. Epigenetics and gene expression.Heredity2010105141310.1038/hdy.2010.5420461105
     [Google Scholar]
  30. XueW. ZhengY. ShenZ. LiL. FanZ. WangW. ZhuZ. ZhaiY. ZhaoJ. KanQ. Involvement of long non‐coding RNAs in the progression of esophageal cancer.Cancer Commun.202141537138810.1002/cac2.1214633605567
     [Google Scholar]
  31. MiaoH. WangL. ZhanH. DaiJ. ChangY. WuF. LiuT. LiuZ. GaoC. LiL. SongX. A long noncoding RNA distributed in both nucleus and cytoplasm operates in the PYCARD-regulated apoptosis by coordinating the epigenetic and translational regulation.PLoS Genet.2019155e100814410.1371/journal.pgen.100814431086376
     [Google Scholar]
  32. WangY. LiangS. YuY. ShiY. ZhengH. Knockdown of SNHG12 suppresses tumor metastasis and epithelial-mesenchymal transition via the Slug/ZEB2 signaling pathway by targeting miR-218 in NSCLC.Oncol. Lett.20191722356236430719111
     [Google Scholar]
  33. WangX. QiG. ZhangJ. WuJ. ZhouN. LiL. MaJ. Knockdown of long noncoding RNA small nucleolar rna host gene 12 inhibits cell growth and induces apoptosis by upregulating mir-138 in nonsmall cell lung cancer.DNA Cell Biol.2017361189290010.1089/dna.2017.383028872894
     [Google Scholar]
  34. LiS. ChenX. LiuX. YuY. PanH. HaakR. SchmidtJ. ZiebolzD. SchmalzG. Complex integrated analysis of lncRNAs-miRNAs-mRNAs in oral squamous cell carcinoma.Oral Oncol.2017731910.1016/j.oraloncology.2017.07.02628939059
     [Google Scholar]
  35. AftabiY. AnsarinK. ShanehbandiD. KhaliliM. SeyedrezazadehE. RahbarniaL. AsadiM. Amiri-SadeghanA. ZafariV. EyvaziS. BakhtiyariN. ZarredarH. Long non‐coding RNAs as potential biomarkers in the prognosis and diagnosis of lung cancer: A review and target analysis.IUBMB Life202173230732710.1002/iub.243033369006
     [Google Scholar]
  36. YangY-R. ZangS-Z. ZhongC-L. LiY-X. ZhaoS-S. FengX-J. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.Int. J. Clin. Exp. Pathol.20147106929693525400777
     [Google Scholar]
  37. WuD. LiY. ZhangH. HuX. Knockdown of Lncrna PVT1 enhances radiosensitivity in non-small cell lung cancer by sponging Mir-195.Cell. Physiol. Biochem.20174262453246610.1159/00048020928848163
     [Google Scholar]
  38. ZhangY. LiX. HouY. FangN. YouJ. ZhouQ. The lncRNA XIST exhibits oncogenic properties via regulation of miR-449a and Bcl-2 in human non-small cell lung cancer.Acta Pharmacol. Sin.201738337138110.1038/aps.2016.13328248928
     [Google Scholar]
  39. ZhouX. XuX. GaoC. CuiY. XIST promote the proliferation and migration of non-small cell lung cancer cells via sponging miR-16 and regulating CDK8 expression.Am. J. Transl. Res.20191196196620631632587
     [Google Scholar]
  40. RohJ. KimB. ImM. JangW. ChaeY. KangJ. YounB. KimW. MALAT1-regulated gene expression profiling in lung cancer cell lines.BMC Cancer202323181881810.1186/s12885‑023‑11347‑737667226
     [Google Scholar]
  41. Yang Geng Pengfei Chen Lei Zhang Xiaojun Li Chao Song Xueting Wei Huiyuan Gong LncRNA MALAT1 regulates growth of carcinoma of the lung through modulating miR-338-3p/PYCR2 axis.Cell. Mol. Biol.202369413314010.14715/cmb/2023.69.4.2137329534
     [Google Scholar]
  42. LiuC. LiH. JiaJ. RuanX. LiuY. ZhangX. High metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) expression promotes proliferation, migration, and invasion of non-small cell lung cancer via ERK/mitogen-activated protein kinase (MAPK) signaling pathway.Med. Sci. Monit.2019255143514910.12659/MSM.91330831293277
     [Google Scholar]
  43. Ying Sun Liming Fan Yixian Li Low expression of LncRNA AFAP1-AS1 inhibits proliferation and promotes apoptosis of non-small cell lung cancer cells through inhibiting wnt signaling pathway.Cell. Mol. Biol.2023691217618010.14715/cmb/2023.69.12.2838063100
     [Google Scholar]
  44. LiH. CuiZ. LvX. LiJ. GaoM. YangZ. BiY. ZhangZ. WangS. LiS. ZhouB. YinZ. Long non-coding RNA HOTAIR function as a competing endogenous RNA for miR-149-5p to promote the cell growth, migration, and invasion in non-small cell lung cancer.Front. Oncol.20201052852052852010.3389/fonc.2020.52852033102210
     [Google Scholar]
  45. LuK. LiW. LiuX. SunM. ZhangM. WuW. XieW. HouY. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression.BMC Cancer201313146146110.1186/1471‑2407‑13‑46124098911
     [Google Scholar]
  46. LvD. BiQ. LiY. DengJ. WuN. HaoS. ZhaoM. Long non-coding RNA MEG3 inhibits cell migration and invasion of non-small cell lung cancer cells by regulating the miR-21-5p/PTEN axis.Mol. Med. Rep.202123319110.3892/mmr.2021.1183033495842
     [Google Scholar]
  47. ShiX. SunM. LiuH. YaoY. KongR. ChenF. SongY. A critical role for the long non‐coding RNA GAS5 in proliferation and apoptosis in non‐small‐cell lung cancer.Mol. Carcinog.201554S1Suppl. 1E1E1210.1002/mc.2212024357161
     [Google Scholar]
  48. XuW.N. ZhengH.L. YangR.Z. LiuT. YuW. ZhengX.F. LiB. JiangS.D. JiangL.S. Mitochondrial NDUFA4L2 attenuates the apoptosis of nucleus pulposus cells induced by oxidative stress via the inhibition of mitophagy.Exp. Mol. Med.2019511111610.1038/s12276‑019‑0331‑231740659
     [Google Scholar]
  49. YangX. MengL. ZhongY. HuF. WangL. WangM. The long intergenic noncoding RNA GAS5 reduces cisplatin-resistance in non-small cell lung cancer through the miR-217/LHPP axis.Aging20211322864288410.18632/aging.20235233418541
     [Google Scholar]
  50. ShenQ. WangH. ZhangL. TP63 functions as a tumor suppressor regulated by GAS5/miR-221-3p signaling axis in human non-small cell lung cancer cells.Cancer Manag. Res.20231521723110.2147/CMAR.S38778136873253
     [Google Scholar]
  51. FuY. LiuL. WuH. ZhengY. ZhanH. LiL. LncRNA GAS5 regulated by FTO-mediated m6A demethylation promotes autophagic cell death in NSCLC by targeting UPF1/BRD4 axis.Mol. Cell. Biochem.2024479355356610.1007/s11010‑023‑04748‑637120495
     [Google Scholar]
  52. JiangN. ZhangX. GuX. LiX. ShangL. Progress in understanding the role of lncRNA in programmed cell death.Cell Death Discov.202171303010.1038/s41420‑021‑00407‑133558499
     [Google Scholar]
  53. WangR.Q. LongX.R. ZhouN.N. ChenD.N. ZhangM.Y. WenZ.S. ZhangL.J. HeF.Z. ZhouZ.L. MaiS.J. WangH.Y. Lnc-GAN1 expression is associated with good survival and suppresses tumor progression by sponging mir-26a-5p to activate PTEN signaling in non-small cell lung cancer.J. Exp. Clin. Cancer Res.20214019910.1186/s13046‑020‑01819‑033407724
     [Google Scholar]
  54. HanB. LncRNA LINC02418 regulates proliferation and apoptosis of non-small cell lung cancer cells by regulating miR-4677-3p/SEC61G.Eur. Rev. Med. Pharmacol. Sci.20192323103541036231841189
     [Google Scholar]
  55. WangT. TangX. LiuY. LncRNA-ATB promotes apoptosis of non-small cell lung cancer cells through MiR-200a/β-Catenin.JBUON20192462280228631983095
     [Google Scholar]
  56. WuJ. HuangX. LiX. ZhouH. ChenX. ChenY. GuoY. HuangJ. HuangH. HuangZ. ChenG. YangZ. ZhangJ. SuW. Suppression of the long non-coding RNA LINC01279 triggers autophagy and apoptosis in lung cancer by regulating FAK and SIN3A.Discov. Oncol.20241513310.1007/s12672‑023‑00855‑438168833
     [Google Scholar]
  57. MoyerV.A. U.S. Preventive Services Task Force Screening for oral cancer: U.S. Preventive services task force recommendation statement.Ann. Intern. Med.2014160155-6010.7326/M13‑256824276469
     [Google Scholar]
  58. AberleD.R. AdamsA.M. BergC.D. BlackW.C. ClappJ.D. FagerstromR.M. GareenI.F. GatsonisC. MarcusP.M. SicksJ.D. National Lung Screening Trial Research Team Reduced lung-cancer mortality with low-dose computed tomographic screening.N. Engl. J. Med.2011365539540910.1056/NEJMoa110287321714641
     [Google Scholar]
  59. YeR. TangR. GanS. LiR. ChengY. GuoL. ZengC. SunY. New insights into long non-coding RNAs in non-small cell lung cancer.Biomed. Pharmacother.202013111077510.1016/j.biopha.2020.11077533152934
     [Google Scholar]
  60. WangN. YaoC. LuoC. LiuS. WuL. HuW. ZhangQ. RongY. YuanC. WangF. Integrated plasma and exosome long noncoding RNA profiling is promising for diagnosing non-small cell lung cancer.Clin. Chem. Lab. Med.202361122216222810.1515/cclm‑2023‑029137387637
     [Google Scholar]
  61. VesovicN. TosicN. Karan DjurasevicT. AndricZ. ZdravkovicD. PavlovicS. JovanovicD. Expression pattern of circulating long non-coding RNA GAS5 as a novel biomarker in non-small cell lung cancer patients.Arch. Med. Sci.202010.5114/aoms.2020.98815
     [Google Scholar]
  62. XieY. ZhangY. DuL. JiangX. YanS. DuanW. LiJ. ZhanY. WangL. ZhangS. LiS. WangL. XuS. WangC. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non‐small cell lung cancer.Mol. Oncol.201812564865810.1002/1878‑0261.1218829504701
     [Google Scholar]
  63. LiZ. ZhuoY. LiJ. ZhangM. WangR. LinL. Long non-coding RNA SNHG4 is a potential diagnostic and prognostic indicator in non-small cell lung cancer.Ann. Clin. Lab. Sci.202151565466234686507
     [Google Scholar]
  64. XiaoT. YanA. TanL. ZhuH. GaoW. LncRNA HOXA‑AS2 is a prognostic and clinicopathological predictor in patients with cancer: A meta‑analysis.Oncol. Lett.202427522622610.3892/ol.2024.1435938586205
     [Google Scholar]
  65. MaX. ChenZ. ChenW. ChenZ. ShangY. ZhaoY. LiL. ZhouC. HeJ. MengX. LncRNA AL139294.1 can be transported by extracellular vesicles to promote the oncogenic behaviour of recipient cells through activation of the Wnt and NF-κB2 pathways in non-small-cell lung cancer.J. Exp. Clin. Cancer Res.20244312010.1186/s13046‑023‑02939‑z38229152
     [Google Scholar]
  66. LiJ. LiY. SunX. WeiL. GuanJ. FuL. DuJ. ZhangX. ChengM. MaH. JiangS. ZhengQ. WangL. Silencing lncRNA-DARS-AS1 suppresses nonsmall cell lung cancer progression by stimulating miR-302a-3p to inhibit ACAT1 expression.Mol. Carcinog.202463475777110.1002/mc.2368638289172
     [Google Scholar]
  67. MiaoX. XiW. BaoY. LncRNA RP11-58O9.2 predicts poor prognosis and promotes progression of non-small cell lung cancer.J. Int. Med. Res.202351100300060523120629510.1177/0300060523120629537871619
     [Google Scholar]
  68. DasariS. Bernard TchounwouP. Cisplatin in cancer therapy: Molecular mechanisms of action.Eur. J. Pharmacol.201474036437810.1016/j.ejphar.2014.07.02525058905
     [Google Scholar]
  69. FloreaA.M. BüsselbergD. Cisplatin as an anti-tumor drug: Cellular mechanisms of activity, drug resistance and induced side effects.Cancers2011311351137110.3390/cancers301135124212665
     [Google Scholar]
  70. WangM. FuY. ZhongC. GaccheR.N. WuP. Long non-coding RNA and Evolving drug resistance in lung cancer.Heliyon2023912e22591e2259110.1016/j.heliyon.2023.e2259138089985
     [Google Scholar]
  71. HuaG. ZengZL. ShiY. ChenW. HeLF. ZhaoGF. LncRNA XIST contributes to cisplatin resistance of lung cancer cells by promoting cellular glycolysis through sponging miR-101-3p.Pharmacology20211069-1049850810.1016/j.yexmp.2021.10463333753110
     [Google Scholar]
  72. SheK. HeS. LuX. YuS. LiM. XiongW. ZhouM. LncRNA SNHG7 promotes non-small cell lung cancer progression and cisplatin resistance by inducing autophagic activity.J. Thorac. Dis.202315115516710.21037/jtd‑22‑182636794139
     [Google Scholar]
  73. MaP. HanW. MengC. TanX. LiuP. DongL. LINC02389/miR-7-5p regulated cisplatin resistance of non-small-cell lung cancer via promoting oxidative stress.Anal. Cell. Pathol.2022202211310.1155/2022/610017636311891
     [Google Scholar]
  74. GongF. DongD. ZhangT. XuW. Long non-coding RNA FENDRR attenuates the stemness of non-small cell lung cancer cells via decreasing multidrug resistance gene 1 (MDR1) expression through competitively binding with RNA binding protein HuR.Eur. J. Pharmacol.201985334535210.1016/j.ejphar.2019.04.02230981768
     [Google Scholar]
  75. ZhaoQ. WangN. LiY. WuQ. WuL. Lnc-TMEM132D-AS1 overexpression reduces sensitivity of non-small cell lung cancer cells to osimertinib. J Southern Med Univ.2023432242250
     [Google Scholar]
  76. ShanK.Z. YangS.F. DengY.J. YueP.Y. DuZ.Q. E2F1-induced long non-coding RNA MCF2L-AS1 modulates Cyclin D1 mRNA stability through ELAVL1 to induce Gefitinib resistance in non-small cell lung cancer.Acta Biochim. Pol.202269479580410.18388/abp.2020_611836257058
     [Google Scholar]
  77. WangS. LiuC. LeiQ. WuZ. MiaoX. ZhuD. YangX. LiN. TangM. ChenY. WangW. Relationship between long non-coding RNA PCAT-1 expression and gefitinib resistance in non-small-cell lung cancer cells.Respir. Res.202122114614610.1186/s12931‑021‑01719‑733980216
     [Google Scholar]
  78. WangP. ChenD. MaH. LiY. LncRNA SNHG12 contributes to multidrug resistance through activating the MAPK/Slug pathway by sponging miR-181a in non-small cell lung cancer.Oncotarget2017848840868410110.18632/oncotarget.2047529137407
     [Google Scholar]
  79. ZhengY. GuoZ. LiY. Long non-coding RNA prostate cancer-associated transcript 6 inhibited gefitinib sensitivity of non-small cell lung cancer by serving as a competing endogenous RNA of miR-326 to up-regulate interferon-alpha receptor 2.Bioengineered20221323785379610.1080/21655979.2022.203141635081872
     [Google Scholar]
  80. PanR. ZhouH. Exosomal transfer of lncRNA H19 promotes erlotinib resistance in non-small cell lung cancer via miR-615-3p/ATG7 axis.Cancer Manag. Res.2020124283429710.2147/CMAR.S24109532606925
     [Google Scholar]
  81. ZuoT. JiangP. FuJ. ZhangY. LncRNA AFAP1-AS1 induces gefitinib resistance of lung adenocarcinoma through the miR-653-5p/AGR2 axis.Ther. Clin. Risk Manag.20231911310.2147/TCRM.S37416236636455
     [Google Scholar]
  82. WangN. ZhaoQ. HuangY. WenC. LiY. BaoM. WuL. Lnc-TMEM132D-AS1 as a potential therapeutic target for acquired resistance to osimertinib in non-small-cell lung cancer.Mol. Omics202319323825110.1039/D2MO00261B36651104
     [Google Scholar]
  83. ShiT. SunW. ShiY-L. WangQ. YanZ-X. ZhangM. LncRNA OSER1-AS1 interacts with miR-612/FOXM1 axis to modulate gefitinib resistance of lung adenocarcinoma.Am. J. Transl. Res.20211331365137633841662
     [Google Scholar]
  84. BingZ. HanJ. ZhengZ. LiangN. FOXO3-induced oncogenic lncRNA CASC9 enhances gefitinib resistance of non-small-cell lung cancer through feedback loop.Life Sci.202128712001210.1016/j.lfs.2021.12001234619168
     [Google Scholar]
  85. MaG. ZhuJ. LiuF. YangY. Long NoncodingR.N.A. Long noncoding RNA LINC00460 promotes the gefitinib resistance of nonsmall cell lung cancer through epidermal growth factor receptor by sponging miR-769-5p.DNA Cell Biol.201938217618310.1089/dna.2018.446230601026
     [Google Scholar]
  86. WangZ. LncRNA CCAT1 downregulation increases the radiosensitivity of non‐small cell lung cancer cells.Kaohsiung J. Med. Sci.202137865466310.1002/kjm2.1238733955133
     [Google Scholar]
  87. WuA. TangJ. DaiY. HuangH. NieJ. HuW. PeiH. ZhouG. Downregulation of long noncoding RNA CRYBG3 enhances radiosensitivity in non-small cell lung cancer depending on p53 status.Radiat. Res.2022198329730510.1667/RADE‑21‑00197.135439322
     [Google Scholar]
  88. ZhongM. FangZ. GuoW. YuX. Translation regulatory long non‐coding RNA 1 negatively regulates cell radiosensitivity via the miR-22-3p/SP1 axis in non-small cell lung cancer.Clin. Respir. J.2024181e13734e1373410.1111/crj.1373438286742
     [Google Scholar]
  89. ZhaoX. JinX. ZhangQ. LiuR. LuoH. YangZ. GengY. FengS. LiC. WangL. WangX. LiQ. Silencing of the lncRNA H19 enhances sensitivity to X-ray and carbon-ions through the miR-130a-3p /WNK3 signaling axis in NSCLC cells.Cancer Cell Int.202121164464410.1186/s12935‑021‑02268‑134863180
     [Google Scholar]
  90. DuR. JiangF. YinY. XuJ. LiX. HuL. WangX. Knockdown of lncRNA X inactive specific transcript (XIST) radiosensitizes non-small cell lung cancer (NSCLC) cells through regulation of miR-16-5p/WEE1 G2 checkpoint kinase (WEE1) axis.Int. J. Immunopathol. Pharmacol.20213510.1177/205873842096608733583218
     [Google Scholar]
  91. YuZ. WangG. ZhangC. LiuY. ChenW. WangH. LiuH. LncRNA SBF2-AS1 affects the radiosensitivity of non-small cell lung cancer via modulating microRNA-302a/MBNL3 axis.Cell Cycle202019330031610.1080/15384101.2019.170801631928130
     [Google Scholar]
/content/journals/cctr/10.2174/0115733947339431241001080157
Loading
Long Non-coding RNAs: Potential Diagnostic and Treatment Targets for Non-small Cell Lung Cancer
Curr Cancer Ther Rev 21, 1041 (2025); https://doi.org/10.2174/0115733947339431241001080157
/content/journals/cctr/10.2174/0115733947339431241001080157
/content/journals/cctr/10.2174/0115733947339431241001080157
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Biomarker; diagnosis; lncRNA; non-small cell lung cancer; radioresistance; treatment

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test